Skip to main content
Cancer Cell International logoLink to Cancer Cell International
. 2013 Oct 18;13:96. doi: 10.1186/1475-2867-13-96

Retraction: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

Neil D Jelly 1,, Issam I Hussain 1, Jennifer Eremin 2, Oleg Eremin 2,3, Mohamed El-Sheemy 1,2
PMCID: PMC3853129  PMID: 24228731

Retraction

This article has been retracted [1] by the authors because errors were noted in the methodology employed in the experiments which invalidate the results reported. The authors apologise for any inconvenience caused.

Contributor Information

Neil D Jelly, Email: canadiannd8@gmail.com.

Issam I Hussain, Email: ihussain@lincoln.ac.uk.

Jennifer Eremin, Email: jenny.eremin@ulh.nhs.uk.

Oleg Eremin, Email: oleg.eremin@ulh.nhs.uk.

Mohamed El-Sheemy, Email: mohamed.el-sheemy@ulh.nhs.uk.

References

  1. Jelly ND, Hussain II, Eremin J, Eremin O, El-Sheemy M. The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int. 2012;12:21. doi: 10.1186/1475-2867-12-21. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Cancer Cell International are provided here courtesy of BMC

RESOURCES